TIMM8AP1: A Potential Drug Target Or Biomarker (G399520)
TIMM8AP1: A Potential Drug Target Or Biomarker
TIMM8AP1 (T-cell intracellular memory molecule associated with the protein Apolipoprotein-L) is a protein that is expressed in various tissues throughout the body, including the brain, spleen, and lymphoid organs. It is a member of the TIMM family of intracellular memory molecules, which are involved in the regulation of cellular processes such as cell survival, apoptosis, and inflammation. TIMM8AP1 has been identified as a potential drug target or biomarker due to its unique structure and the involvement of cellular processes that are relevant to a variety of diseases.
The TIMM8AP1 protein is composed of 254 amino acid residues and has a molecular weight of 31 kDa. It is expressed in a variety of tissues, including the brain, spleen, thymus, spleen lymphoid organs, and peripheral blood. It is highly conserved across different species, which suggests that it has an important role in the development and maintenance of cellular processes in multicellular organisms.
One of the unique features of TIMM8AP1 is its localization to the endoplasmic reticulum (ER) and its association with the protein Apolipoprotein-L (APOLIPOPROTEIN L or ALP). APOLIPOPROTEIN L is a protein that is synthesized in the liver and is involved in the transport of fatty acids into the bloodstream. It is also known as very-low-density lipoprotein (VLDL) protein. The association between TIMM8AP1 and APOLIPOPROTEIN L suggests that TIMM8AP1 may be involved in the regulation of lipid metabolism, which is a key aspect of various diseases, including cardiovascular disease, obesity, and diabetes.
Another potential role of TIMM8AP1 is its involvement in the regulation of cellular apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells in the body. It is regulated by a variety of factors, including the expression of pro- apoptotic and anti-apoptotic genes. TIMM8AP1 has been shown to be involved in the regulation of apoptosis in various tissues, including the brain. It has been shown to induce cell apoptosis in a variety of cell types, including cancer cells, and to play a role in the development of neurodegenerative diseases.
In addition to its potential involvement in apoptosis, TIMM8AP1 is also involved in the regulation of cellular signaling pathways. It has been shown to be involved in several signaling pathways that are involved in the regulation of cellular processes, including cell survival, angiogenesis, and inflammation . It is also involved in the regulation of cellular adhesion, which is a key aspect of the development of cancer.
Given its unique structure and the involvement of cellular processes that are relevant to a variety of diseases, TIMM8AP1 is an attractive candidate for further study as a potential drug target or biomarker. Research into its functions and potential clinical applications is currently being conducted by a variety of research groups, including those at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Cancer Institute (NCI).
In conclusion, TIMM8AP1 is a protein that is expressed in various tissues throughout the body and has been identified as a potential drug target or biomarker due to its unique structure and the involvement of cellular processes that are relevant to a variety of diseases. Further research is needed to fully understand its functions and potential clinical applications.
Protein Name: Translocase Of Inner Mitochondrial Membrane 8A Pseudogene 1
The "TIMM8AP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TIMM8AP1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
TIMM8B | TIMM9 | TIMMDC1 | TIMP1 | TIMP2 | TIMP3 | TIMP4 | TINAG | TINAGL1 | TINCR | TINF2 | TIPARP | TIPARP-AS1 | TIPIN | TIPRL | TIRAP | TIRAP-AS1 | TJAP1 | TJP1 | TJP2 | TJP3 | TK1 | TK2 | TKFC | TKT | TKTL1 | TKTL2 | TLCD1 | TLCD2 | TLCD3A | TLCD3B | TLCD4 | TLCD4-RWDD3 | TLCD5 | TLDC2 | TLE1 | TLE1-DT | TLE2 | TLE3 | TLE4 | TLE5 | TLE6 | TLK1 | TLK2 | TLL1 | TLL2 | TLN1 | TLN2 | TLNRD1 | TLR1 | TLR10 | TLR12P | TLR2 | TLR3 | TLR4 | TLR5 | TLR6 | TLR7 | TLR8 | TLR8-AS1 | TLR9 | TLX1 | TLX1NB | TLX2 | TLX3 | TM2D1 | TM2D2 | TM2D3 | TM4SF1 | TM4SF1-AS1 | TM4SF18 | TM4SF19 | TM4SF19-AS1 | TM4SF19-DYNLT2B | TM4SF20 | TM4SF4 | TM4SF5 | TM6SF1 | TM6SF2 | TM7SF2 | TM7SF3 | TM9SF1 | TM9SF2 | TM9SF3 | TM9SF4 | TMA16 | TMA7 | TMBIM1 | TMBIM4 | TMBIM6 | TMC1 | TMC2 | TMC3 | TMC4 | TMC5 | TMC6 | TMC7 | TMC8 | TMCC1 | TMCC1-DT
